.Pharmacolibrary.Drugs.L_AntineoplasticAndImmunomodulatingAgents.L01A_AlkylatingAgents.L01AD05_Fotemustine.Fotemustine

Information

name:Fotemustine
ATC code:L01AD05
route:intravenous
n-compartments2

Fotemustine is an alkylating antineoplastic agent of the nitrosourea class, used primarily in the treatment of malignant melanoma, especially with metastases to the brain, and sometimes for primary brain tumors. It is approved in some European countries but not in the United States.

Pharmacokinetics

Pharmacokinetic parameters reported in adult cancer patients (malignant melanoma) after intravenous administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos